PlainIndex

ETF comparison

HEFA vs IEMG

International Developed vs International Emerging.

iShares Currency Hedged MSCI EAFE ETF · iShares Core MSCI Emerging Markets ETF

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of HEFA and IEMG would leave roughly 0.0% of each dollar exposed to the same underlying securities.

HEFA only 0.0% Shared 0.0% IEMG only 0.0%
In HEFA only
0 positions
Shared
0 positions
In IEMG only
0 positions

Holdings data for HEFA covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for IEMG covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

HEFA

iShares Currency Hedged MSCI EAFE ETF

iShares · International Developed

75 composite / 100
Expense ratio
0.35%
Net assets
$7.01B
TTM yield
3.15%
Top-10 conc.
—
IEMG

iShares Core MSCI Emerging Markets ETF

iShares · International Emerging

89 composite / 100
Expense ratio
0.090%
Net assets
$151.17B
TTM yield
2.37%
Top-10 conc.
—

Sub-score comparison

65
Cost
91
71
Tax efficiency
72
93
Liquidity
100
N/A
Concentration
N/A
—
Tracking quality
—
HEFA sub-score IEMG

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

IEMG is 26 bps cheaper than HEFA. On a $100,000 position that's about $260/yr more in fees for HEFA.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in HEFA

0 total

Every HEFA position is also held by IEMG.

Only in IEMG

0 total

Every IEMG position is also held by HEFA.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.